Results 241 to 250 of about 2,819,150 (289)
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley +1 more source
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung +6 more
wiley +1 more source
Risk Management of Medication Errors: Improving the Quality of Pharmacotherapeutic Practice. [PDF]
Despott RA, Vella Bonanno P, Gauci C.
europepmc +1 more source
Systematic Evaluation of Australian Risk Management Plans for Biologic Medicines. [PDF]
Ho JN +4 more
europepmc +1 more source
Correction: Leveraging real-world data for safety signal detection and risk management in pre- and post-market settings. [PDF]
Gavin KM, Sundermann ML, Wieland A.
europepmc +1 more source
Correction: Occupational Health Nurses' Perceptions in Work Ability Risk Management and Analysis. [PDF]
Sirkka J, Suhonen R, Liira J, Stolt M.
europepmc +1 more source
Evaluating the Impact of a Preoperative Risk Management Program on Outcomes Following Total Joint Arthroplasty: A Retrospective Cohort Study. [PDF]
Dlott C +4 more
europepmc +1 more source

